``` REGISTERED CHARITY NUMBER: 1101433 ``` ``` Report of the Trustees and ``` ``` Financial Statements ``` ``` for the Year Ended 31 October 2021 ``` ``` for ``` ## **`EPSOM MEDICAL RESEARCH`** ``` Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ## **`EPSOM MEDICAL RESEARCH`** ``` Contents of the Financial Statements for the Year Ended 31 October 2021 ``` ||**`Page`**| |---|---| |**`Report of the Trustees`**|`1 to 2`| |**`Independent Examiner's Report`**|`3`| |**`Statement of Financial Activities`**|`4`| |**`Balance Sheet`**|`5`| |**`Notes to the Financial Statements`**|`6 to 10`| |**`Detailed Statement of Financial Activities`**|`11`| ## **`EPSOM MEDICAL RESEARCH`** ## **`Report of the Trustees`** ``` for the Year Ended 31 October 2021 ``` ``` Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended 31October2021.ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingby Charities: StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with the FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS 102)(effective1 January 2019). ``` ## **`OBJECTIVES AND ACTIVITIES`** ## **`Objectives and aims`** ``` TheobjectivesoftheEpsomMedicalResearchareinthefieldofresearchwithintheareas of rheumatology, general medicine, inflammation, neuroscience and cancer. ``` ## **`ACHIEVEMENT AND PERFORMANCE`** ## **`Charitable activities in the year`** ``` The Charity supported research into the areas defined in its objectives during the year. ``` ## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** ## **`Governing document`** ``` Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated charity. ``` ## **`REFERENCE AND ADMINISTRATIVE DETAILS`** ## **`Registered Charity number`** ``` 1101433 ``` ## **`Principal address`** ``` 85 Rydens Road Elmbridge Walton-on-Thames Surrey KT12 3AN ``` ## **`Trustees`** ``` Dr. L G Darlington Ms S Kumar K W D Ramsey ``` ## **`Independent Examiner`** ``` Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ``` Page 1 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Report of the Trustees`** ``` for the Year Ended 31 October 2021 ``` ``` Approved by order of the board of trustees on 22 August 2022 and signed on its behalf by: ``` ``` Dr. L G Darlington - Trustee ``` ``` Page 2 ``` ``` Independent Examiner's Report to the Trustees of ``` ``` Epsom Medical Research ``` ## **`Independent examiner's report to the trustees of Epsom Medical Research`** ``` I reporttothecharitytrusteesonmyexaminationoftheaccountsofEpsomMedicalResearch(the Trust) for the year ended 31 October 2021. ``` ## **`Responsibilities and basis of report`** ``` AsthecharitytrusteesoftheTrustyouareresponsibleforthepreparationoftheaccountsin accordance with the requirements of the Charities Act 2011 ('the Act'). ``` ``` I reportin respectofmyexaminationoftheTrust'saccountscarriedoutundersection145oftheAct and incarryingoutmyexaminationIhavefollowedallapplicableDirectionsgivenbytheCharity Commission under section 145(5)(b) of the Act. ``` ## **`Independent examiner's statement`** ``` Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in connection with the examination giving me cause to believe that in any material respect: ``` `1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or` `2. the accounts do not accord with those records; or` `3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.` ``` Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be reached. ``` ``` Mr Ryan Cottington FCCA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ``` 22 August 2022 ``` ``` Page 3 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Statement of Financial Activities`** ## **`for the Year Ended 31 October 2021`** |**`2021`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
**`47,105`**
**`EXPENDITURE ON`**
**`Charitable activities`**
`Grants`
**`37,276`**
`Other`
**`1,645`**
**`Total`**
**`38,921`**
**`NET INCOME/(EXPENDITURE)`**
**`8,184`**
**`RECONCILIATION OF FUNDS`**
**`Total funds brought forward`**
**`(213,538)`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`(205,354)`**|`2020`
`Total`
`funds`
`£`
`45,395`
`62,465`
`1,682`
`64,147`
`(18,752)`
`(194,786)`
`(213,538)`| |---|---| ``` The notes form part of these financial statements ``` ``` Page 4 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Balance Sheet`** ## **`31 October 2021`** |**`2021`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`CURRENT ASSETS`**
`Debtors`
`4`
**`8,420`**
`Cash at bank`
**`14,496`**
**`22,916`**
**`CREDITORS`**
`Amounts falling due within one year`
`5`
**`(228,270)`**
**`NET CURRENT ASSETS/(LIABILITIES)`**
**`(205,354)`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`(205,354)`**
**`NET ASSETS/(LIABILITIES)`**
**`(205,354)`**
**`FUNDS`**
`6`
`Unrestricted funds`
**`(205,354)`**
**`TOTAL FUNDS`**
**`(205,354)`**|`2020`
`Total`
`funds`
`£`
`9,288`
`10,382`
`19,670`
`(233,208)`
`(213,538)`
`(213,538)`
`(213,538)`
`(213,538)`
`(213,538)`| |---|---| ``` ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on 22 August 2022 and were signed on its behalf by: ``` ``` L G Darlington - Trustee ``` ``` The notes form part of these financial statements ``` ``` Page 5 ``` ``` EPSOM MEDICAL RESEARCH ``` ``` Notes to the Financial Statements for the Year Ended 31 October 2021 ``` ## **`1. ACCOUNTING POLICIES`** ## **`Basis of preparing the financial statements`** ``` Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities: StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance withtheFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102) (effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard applicableintheUKandRepublicofIreland'andtheCharitiesAct2011.Thefinancial statements have been prepared under the historical cost convention. ``` ## **`Income`** ``` Allincomeis recognisedin theStatementofFinancialActivitiesoncethecharityhasentitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ``` ## **`Expenditure`** ``` Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation committingthe charityto that expenditure,it is probablethat a transferof economicbenefitswill be requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have been allocated to activities on a basis consistent with the use of resources. ``` ``` Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a commitment but not accrued as expenditure. ``` ## **`Taxation`** ``` The charity is exempt from tax on its charitable activities. ``` ## **`Fund accounting`** ``` Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the trustees. ``` ``` Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity. Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted purposes. ``` ``` Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial statements. ``` ``` continued... ``` ``` Page 6 ``` ``` EPSOM MEDICAL RESEARCH ``` ``` Notes to the Financial Statements - continued for the Year Ended 31 October 2021 ``` ## **`2. TRUSTEES' REMUNERATION AND BENEFITS`** ``` Therewere no trustees'remunerationor otherbenefitsfor the year ended 31 October2021nor for the year ended 31 October 2020. ``` ## **`Trustees' expenses`** ``` Therewerenotrustees'expensespaidfortheyearended31October2021norfortheyear ended 31 October 2020. ``` ## **`3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`** ||`Unrestricte`| |---|---| ||`fund`| ||`£`| |**`INCOME AND ENDOWMENTS FROM`**|| |`Donations and legacies`|`45,395`| |**`EXPENDITURE ON`**|| |**`Charitable activities`**|| |`Grants`|`62,465`| |`Other`|`1,682`| |**`Total`**|`64,147`| |**`NET INCOME/(EXPENDITURE)`**|`(18,752)`| |**`RECONCILIATION OF FUNDS`**|| |**`Total funds brought forward`**|`(194,786)`| |**`TOTAL FUNDS CARRIED FORWARD`**|`(213,538)`| ``` continued... ``` ``` Page 7 ``` ``` for the Year Ended 31 October 2021 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Notes to the Financial Statements - continued`** |**`4.`**
**`DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`Other debtors`
**`5.`**
**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`Other creditors`
`Accruals and deferred income`
**`6.`**
**`MOVEMENT IN FUNDS`**
`At`
`1/11/20`
`£`
**`Unrestricted funds`**
`General fund`
**`(213,538)`**
**`TOTAL FUNDS`**
**`(213,538)`**
`Net movement in funds, included in the above are as follows:`
`Incoming`
`resources`
`£`
**`Unrestricted funds`**
`General fund`
**`47,105`**
**`TOTAL FUNDS`**
**`47,105`**|**`2021`**
`2020`
**`£`**
`£`
**`8,420`**
`9,288`
**`2021`**
`2020`
**`£`**
`£`
**`208,610`**
`208,610`
**`19,660`**
`24,598`
**`228,270`**
`233,208`
`Net`
`movement`
`At`
`in funds`
`31/10/21`
`£`
`£`
**`8,184`**
**`(205,354)`**
**`8,184`**
**`(205,354)`**
`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
**`(38,921)`**
**`8,184`**
**`(38,921)`**
**`8,184`**| |---|---| ``` continued... ``` ``` Page 8 ``` ``` Notes to the Financial Statements - continued for the Year Ended 31 October 2021 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`6. MOVEMENT IN FUNDS - continued`** ## **`Comparatives for movement in funds`** |**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**
`Comparative net movement in funds, included in the above a`
**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`At`
`1/11/19`
`£`
`(194,786)`
`(194,786)`
`re as follows:`
`Incoming`
`resources`
`£`
`45,395`
`45,395`|`Net`
`movement`
`At`
`in funds`
`31/10/20`
`£`
`£`
`(18,752)`
`(213,538)`
`(18,752)`
`(213,538)`
`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
`(64,147)`
`(18,752)`
`(64,147)`
`(18,752)`| |---|---|---| ||`r`
|| ``` A current year 12 months and prior year 12 months combined position is as follows: ``` |**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`At`
`1/11/19`
`£`
`(194,786)`
`(194,786)`|`Net`
`movement`
`in funds`
`£`
`(10,568)`
`(10,568)`|`At`
`31/10/21`
`£`
`(205,354)`
`(205,354)`| |---|---|---|---| ``` continued... ``` ``` Page 9 ``` ``` Notes to the Financial Statements - continued for the Year Ended 31 October 2021 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`6. MOVEMENT IN FUNDS - continued`** ``` Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in the above are as follows: ``` |**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`Incoming`
`Resources`
`Movement`
`resources`
`expended`
`in funds`
`£`
`£`
`£`
`92,500`
`(103,068)`
`(10,568)`
`92,500`
`(103,068)`
`(10,568)`| |---|---| ## **`7. RELATED PARTY DISCLOSURES`** ``` There were no related party transactions for the year ended 31 October 2021. ``` ``` Page 10 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Detailed Statement of Financial Activities`** ``` for the Year Ended 31 October 2021 ``` |**`INCOME AND ENDOWMENTS`**
**`Donations and legacies`**
`Donations`
`Gift aid`
`Legacies`
**`Total incoming resources`**
**`EXPENDITURE`**
**`Charitable activities`**
`Research salaries`
`Research expenses`
**`Support costs`**
**`Governance costs`**
`Accountancy and legal fees`
`Total resources expended`
**`Net income/(expenditure)`**|`2021`
`£`
**`33,682`**
**`8,423`**
**`5,000`**
**`47,105`**
**`47,105`**
**`32,300`**
**`4,976`**
**`37,276`**
**`1,645`**
**`38,921`**
**`8,184`**|`2020`
`£`
`36,316`
`9,079`
`-`
`45,395`
`45,395`
`34,062`
`28,403`
`62,465`
`1,682`
`64,147`
`(18,752)`| |---|---|---| ``` This page does not form part of the statutory financial statements ``` ``` Page 11 ```